These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24613340)

  • 21. Should family physicians follow the new ACC/AHA cholesterol treatment guideline? Not completely: why it is right to drop LDL-C targets but wrong to recommend statins at a 7.5% 10-year risk.
    Hayward RA
    Am Fam Physician; 2014 Aug; 90(4):223-4. PubMed ID: 25250995
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms of disease: HDL metabolism as a target for novel therapies.
    Rader DJ
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4(2):102-9. PubMed ID: 17245404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-lowering medications: what the new guidelines and data mean to women.
    Schwartz JB
    J Gend Specif Med; 2001; 4(2):9-13. PubMed ID: 11480105
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?
    Knopp RH; Paramsothy P
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):136-7. PubMed ID: 16932272
    [No Abstract]   [Full Text] [Related]  

  • 25. The anti-thrombotic effects of statins.
    Kearney D; Fitzgerald D
    J Am Coll Cardiol; 1999 Apr; 33(5):1305-7. PubMed ID: 10193731
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of lipid modification on progression of coronary calcification.
    McCullough PA
    J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S115-9. PubMed ID: 16251246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?].
    Windler E
    Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000
    [No Abstract]   [Full Text] [Related]  

  • 28. Cholesterol, lipids, and statins.
    Ballantyne CM
    Tex Heart Inst J; 2005; 32(3):378-9. PubMed ID: 16392223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New statin introduction. With more power against hypercholesterolemia].
    MMW Fortschr Med; 2002 Dec; 144(50):64. PubMed ID: 14610873
    [No Abstract]   [Full Text] [Related]  

  • 30. Overview of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.
    Robinson JG
    Future Cardiol; 2014 Mar; 10(2):149-52. PubMed ID: 24762237
    [No Abstract]   [Full Text] [Related]  

  • 31. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
    Olsson AG; Nilsson PM
    Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
    [No Abstract]   [Full Text] [Related]  

  • 32. Statins and aortic stenosis in the context of ratio of low- to high-density lipoprotein cholesterol.
    Yilmaz MB
    J Am Coll Cardiol; 2007 Jul; 50(3):289-90; author reply 290. PubMed ID: 17631225
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholesterol treatment and changes in guidelines in an academic medical practice.
    Schoen MW; Salas J; Scherrer JF; Buckhold FR
    Am J Med; 2015 Apr; 128(4):403-9. PubMed ID: 25460526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
    Barter P; Gotto AM; LaRosa JC; Maroni J; Szarek M; Grundy SM; Kastelein JJ; Bittner V; Fruchart JC;
    N Engl J Med; 2007 Sep; 357(13):1301-10. PubMed ID: 17898099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lipid lowering by rosuvastatin: how do statins differ?].
    Laufs U
    Dtsch Med Wochenschr; 2015 Mar; 140(5):313. PubMed ID: 25734669
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HMG-CoA reductase inhibitors].
    Yamamoto A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():578-86. PubMed ID: 11347135
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic polymorphisms and statin therapy.
    Zineh I
    JAMA; 2004 Sep; 292(11):1302-3. PubMed ID: 15367547
    [No Abstract]   [Full Text] [Related]  

  • 40. The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.
    Devroey D; Velkeniers B; Duquet W; Betz W
    Int J Cardiol; 2005 May; 101(2):231-5. PubMed ID: 15882669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.